Dr. Mzia Kutateladze, Eliava Institute of Bacteriophage, Georgia will join the Phage Therapy Congress to share her expertise and present her latest research in a talk entitled “Bacteriophage Therapy: From Soviet Clinical Experience to Current Activities at the Eliava Institute”.
In the pre-antibiotic era of the early 20th century, phage therapy was becoming a powerful weapon against bacterial infections in many different countries. Unfortunately, phage treatment and research was largely forgotten as antibiotics became widely available. Phage therapy remained a standard part of the healthcare systems in Eastern Europe and the USSR during the second half of the 20th century.
Phage preparations were used for diagnostic, therapeutic and prophylactic purposes to combat various bacterial infectious diseases. Nowadays, the rapid propagation and spread of multi-drug resistant bacterial strains is leading to renewed interest in phage therapy Worldwide.
George Eliava Institute of Bacteriophages, Microbiology and Virology (Eliava Institute, Tbilisi, Georgia) is perhaps the most famous institution in the world focused on the study and application of bacteriophages. “Eliava” phages are successfully used to treat acute, as well chronic infections caused by different bacterial pathogens, including multi-drag resistant bacterial strains.
Join the congress to benefit from the experience of professionals like Dr. Kutateladze.
Targeting Phage Therapy 2023
June 1-2, 2023 – Paris, France